Karen Sterling
Stock Analyst at WBB Securities
(2.69)
# 2,902
Out of 5,152 analysts
9
Total ratings
60%
Success rate
19.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Karen Sterling
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TTRX Turn Therapeutics | Upgraded: Hold | $10 | $8.89 | +12.49% | 4 | Oct 23, 2026 | |
| CTSO Cytosorbents | Initiated Coverage: Buy | $9.5 | $5.57 | +70.71% | 2 | Oct 21, 2026 | |
| REGN Regeneron Pharmaceuticals | Initiated Coverage: Hold | n/a | $945.53 | n/a | 1 | Sep 15, 2023 | |
| NRXS NeurAxis | Initiated Coverage: Buy | $7.5 | $4.87 | n/a | 1 | Aug 23, 2023 | |
| VRTX Vertex Pharmaceuticals | Initiated Coverage: Hold | n/a | $536.45 | n/a | 1 | May 25, 2023 |
Turn Therapeutics
Oct 23, 2026
Upgraded: Hold
Price Target: $10
Current: $8.89
Upside: +12.49%
Cytosorbents
Oct 21, 2026
Initiated Coverage: Buy
Price Target: $9.5
Current: $5.57
Upside: +70.71%
Regeneron Pharmaceuticals
Sep 15, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $945.53
Upside: n/a
NeurAxis
Aug 23, 2023
Initiated Coverage: Buy
Price Target: $7.5
Current: $4.87
Upside: n/a
Vertex Pharmaceuticals
May 25, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $536.45
Upside: n/a